scispace - formally typeset
Open AccessJournal ArticleDOI

EMT and inflammation: inseparable actors of cancer progression

TLDR
The interconnections between EMT programs and cellular and molecular actors of inflammation are described, and data linking the EMT/inflammation axis to metastasis is recapitulate.
About
This article is published in Molecular Oncology.The article was published on 2017-07-01 and is currently open access. It has received 368 citations till now. The article focuses on the topics: Epithelial–mesenchymal transition & Cancer cell.

read more

Citations
More filters
Journal ArticleDOI

Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer

TL;DR: In this article , the authors investigated the dynamics of a regulatory network connecting the drivers of androgen receptor splice variant-mediated androgen independence and those of epithelial-mesenchymal transition.
Journal ArticleDOI

Immunohistochemical Expression of MMP-9, TIMP-1, and Vimentin and its Correlation With Inflammatory Reaction and Clinical Parameters in Oral Epithelial Dysplasia.

TL;DR: In this paper, the authors investigated the immunoexpression of matrix metalloproteinase 9 (MMP-9), TIMP-1 and vimentin (VIM) and its association with the inflammatory reaction (IR) and clinical parameters in oral epithelial dysplasia.
Journal ArticleDOI

MiR-143-5p inhibits proliferation, invasion, and epithelial to mesenchymal transition of colorectal cancer cells by downregulation of HMGA2

TL;DR: MiR-143-5p inhibits the malignant progression of CRC by regulating HMGA2 expression and is expected to provide new therapeutic approaches for clinical treatment of CRC.
Journal ArticleDOI

The portrayal of macrophages as tools and targets: A paradigm shift in cancer management.

TL;DR: In this paper , the potential of targeting macrophages in order to improve current strategies for tumor management is emphasized, where the authors have discussed the role of macrophage in various stages of tumor progression epithelial-to-mesenchymal transition (EMT), invasion, maintaining the stability of circulating tumor cells (CTCs) in blood, and establishing a premetastatic niche along with various cytokines and chemokines involved in these processes.
References
More filters
Journal ArticleDOI

Monocyte chemoattractant protein-1 (MCP-1): an overview.

TL;DR: This review will discuss the biological processes and the structure and function of CCL2, one of the key chemokines that regulate migration and infiltration of monocytes/macrophages.
Journal ArticleDOI

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

TL;DR: It is shown that most human tumors constitutively express IDO, and that expression of IDO by immunogenic mouse tumor cells prevents their rejection by preimmunized mice, suggesting that the efficacy of therapeutic vaccination of cancer patients might be improved by concomitant administration of an IDO inhibitor.
Journal ArticleDOI

Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

TL;DR: A role for EMT in the blood-borne dissemination of human breast cancer is supported as both single cells and multicellular clusters, expressing known EMT regulators, including transforming growth factor (TGF)–β pathway components and the FOXC1 transcription factor.
Journal ArticleDOI

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer

TL;DR: This study functionally probes the role of EMT in PDAC by generating mouse models of PDAC with deletion of Snail or Twist, two key transcription factors responsible for EMT, and highlights the importance of combining EMT inhibition with chemotherapy for the treatment of pancreatic cancer.
Journal ArticleDOI

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

TL;DR: The potential of an EMT-targeting strategy, in conjunction with conventional chemotherapies, for breast cancer treatment is suggested, using a mesenchymal-specific Cre-mediated fluorescent marker switch system in spontaneous breast-to-lung metastasis models.
Related Papers (5)